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Abstract.  The ternary complex involving link protein 
(LP), proteoglycan monomer, and hyaluronic acid 
(HA) is an important component of the extracellular 
matrix of cartilage. LP contains tandemly repeated se- 
quences that were tested for their ability to interact 
with HA. A solid-phase assay was developed in which 
LP could specifically bind to immobilized HA. Detec- 
tion of LP was by means of an antiserum directed 
against a peptide from the NH2-terminal  half of LP. 
LP binding to HA could be inhibited with mAb 8A4 
(Caterson, B., J.  R. Baker, J.  E. Christner, Y. Lee, 
and M.  Lentz. 1985. J. Biol. Chem. 260:IB48-11356). 
Using synthetic peptides that correspond to specific 
amino acid sequences of chicken LP (D~k, E, I. Kiss, 
K. J.  Sparks, W. S. Argraves, G. Hampikian, and P. E 
Goetinck.  I986. Proc. Natl. Acad. Sci. USA. 
83:3766-3770)  the epitopes for mAb 8A4 were deter- 
mined to reside in peptides GlyZ17-Pro  226 and Arg  316- 
Arg3ZL These two peptides were also capable of in- 
hibiting the interaction between LP and HA. The pep- 
tide TrpZ42-Va1251 and Pro339-Va1348 could also inhibit the 
interaction between LP and HA. All four peptides re- 
side in the tandemly repeated domains of LP and they 
contain clusters of positively charged amino acids. 
Polylysine could not inhibit the interaction of LP with 
HA. The results indicate that the sites for interaction 
with HA are in the tandemly repeated sequences of 
LP and that there are four potential sites available  for 
that interaction. 
T 
HE extracellular matrix of cartilage consists of a num- 
ber of interacting macromolecules that are unique to 
that tissue. The most studied group of these molecules 
are those that make up the ternary complex involving pro- 
teoglycan monomer, link protein (LP) ~, and hyaluronic acid 
(HA) (10). As many as 100 proteoglycan monomers and LPs 
can be found to interact with a single HA polymer (8). Al- 
though the molecular basis for the formation of the ternary 
complex is not known, it is thought that LP and proteoglycan 
monomer interact with HA in a similar manner and there is 
evidence that this type of  interaction is different from that ob- 
served between LP and proteoglycan monomer (12). Chemi- 
cal modification of either LP (14) or proteoglycan (9) have 
implicated  arginine  and  lysine  residues  in the binding  of 
these macromolecules to HA. Also, proteoglycan monomers 
that have been synthesized in the presence  of the arginine 
analog, canavanine, have a reduced ability to interact with 
HA (Bowik, C. C., and P. E Goetinck, manuscript in prepa- 
ration). When uronic acid residues in HA are modified, the 
interaction with proteoglycan monomers  is also eliminated 
(4). Taken together these observations suggest an ionic type 
of interaction  between positively charged  amino acid res- 
idues in LP and proteoglycan monomer and the negatively 
charged uronic acid residues in HA. The recent elucidation 
of the complete amino acid sequence of rat chondrosarcoma 
1.  Abbreviations  used  in  this  paper:  GAG,  glycosaminoglycan;  HA, 
hyaluronic acid; KLH, Keyhole Limpet Hemocyanin; LP,  link protein. 
(16) and chicken (5) LP has revealed that these molecules are 
composed of three discrete domains. The first domain (Do- 
main I) consists of the NH2-terminal half of the molecule 
and it possesses homologies with immunoglobulin-like pro- 
teins (2). The second half  of  the molecule contains tandemly 
repeated sequences (5, 6, 16) (Domains Ha and IIb) that have 
homologies with an amino acid sequence of the HA-binding 
region of  cartilage proteoglycan monomer (17). Based on the 
sequence homology between LP and proteoglycan monomer 
it has been suggested (5,  17) that the tandemly repeated se- 
quences contain the sites for interaction with HA. Indeed, 
the tandem repeats contain four clusters of  positively charged 
amino acids that could be involved in the interaction of link 
protein with HA. This communication reports on the identi- 
fication of the amino acid sequences in LP that are involved 
in the binding of this molecule to HA. 
Materials and Methods 
Purification of  LP and Proteoglycan Monomer 
Cartilaginous xyphoid processes of 4-6-wk-old White Leghorn chickens 
were extracted using dissociative procedures. LP and proteoglycan mono- 
mer were purified by sequential associative and dissociative CsC1 centrifu- 
gation of the extracts according to the method of Hascall and Sajdera (11). 
All extractions and centrifugations were done in the presence of  the protease 
inhibitors introduced by Oegema et al. (18). LP obtained from the second 
CsCI gradient was separated from any residual proteoglycan by chromatog- 
raphy on DEAE-cellulose in the presence of 8 M urea (1). LP was recovered 
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SDS-PAGE (13), two bands were revealed  when stained for protein with 
Coomassie Blue. These had relative molecular masses of 48,000 and 42,000 
D as previously  reported (15). Upon transfer of the proteins (which were 
subjected to electrophoresis)  to nitrocellulose  (21), both hands bound to a 
polyclonal  antiserum directed  against purified avian LP (15) and with the 
antiserum directed against peptide Gly~~176 n2 described in this paper. 
Synthetic LP Peptides 
Peptides corresponding to specific amino acid sequences of LP were synthe- 
sized using an automated  peptide synthesizer (model No. 430A;  Applied 
Biosystems,  Inc., Hauppague,  NY) equipped  with the chemistry provided 
by the manufacturer.  After cleavage from the resin with hydrogen fluoride, 
the peptides were washed with cold ethyl ether, redissolved  in water, and 
lyophilized.  Coupling efficiency was monitored after the addition of each 
residue.  Peptide purity was tested by HPLC on a C-18 column (3.9 mm in- 
ternal diameter x  300 ram; Waters Chromatography  Division, Millipore 
Corp.  Milford, MA; microBondapark). In every instance the chromato- 
grams gave a single major peak indicating an estimated  purity of 90% or 
greater.  The numbering system used in the identification of the peptides is 
based on that introduced by De~k et al. (5) in which the initiation methio- 
nine of the D-amino acid signal peptide is considered as the first residue. 
The following synthetic  peptides  were used in this study: 
Peptide  from Domain 1: 
Glym-His-His-Arg-Lys-Ser-Tyr-Gly-Lys-Tyr-Gln-Gly-Arg  ~r2 (Peptide  Gly  ~~ 
Argm); 
Peptides  from Domain lla: 
Asn2~  - 
Arg-Glu-Pro  226 (Peptide  Asn2~ 
Gln2tT-Tyr-Pro-Ile-Thr-Lys-Pro-Arg-Glu-Pro 226 (Peptide  Gln2]7-Pro2Zt); 
Trp24Z-Asp-Lys-Glu-Arg-Ser-Arg-Tyr-Asp-Val  TM  (Peptide  Trp2+2Val2m); 
Peptides  from Domain lib: 
Asp3~  - 
Arg-Lys-Arg 325 (Peptide  Asp3~ 
Arg3m-Tyr-Pro-Ile-Ser-Arg-Pro-Arg-Lys-Arg  325 (Peptide Arg316-Arg325); and 
Pro339-Asp-Lys-Lys-His-Lys-Leu-Tyr-Gly-Va1348 (Peptide  Pro339-Va1348). 
Polylysine  (8-12)  was purchased from IC Immunobiologicals  (Lisle,  IL). 
Antibodies 
A  polyclonal  antiserum was generated in rabbits against peptide Gly  ~~ 
Arg  H2 coupled to Keyhole Limpet Hemocyanin (KLH) by means of N-suc- 
cinimidyl-3-(pyridylithio)propionate  (SPDP) to a  cysteine  residue intro- 
duced at the amino group of Gly  m~176  during the synthesis of the peptide.  The 
conditions were based on those described by Pierschbacher et al. (19). For 
each immunization 3 mg of the peptide was conjugated to I mg of KLH with 
0.5 mg of SPDP in 1.5 ml of PBS. For the first immunization the mixture 
was combined with an equal volume of Freund's complete adjuvant, and for 
booster immunizations with Freund's incomplete adjuvant.  The anti-LP 
monoclonal antibody 8A4 (3) vats obtained as a culture supernatant from 
the Developmental  Studies  Hybridoma Bank maintained by contract NO- 
HD-6-2915 from National Institute of Child Health and Human Develop- 
ment (NICHD, Bethesda,  MD). Goat anti-rabbit and goat anti-mouse IgG 
alkaline phosphatase  conjugates  were obtained from BioRad  Laboratories 
(Richmond, CA). 
Binding Assays 
All macromolecular interactions were studied using ELISAs (7). Immobili- 
zation of macromolecules to microtiter plates (EIA, Lindbro; Flow Labora- 
tories, McLean, VA) was carded out in 0.05 M sodium carbonate buffer, 
pH 9.6, overnight at room temperature+ All subsequent additions in the bind- 
ing assays were done for 1 h in PBS containing  0.05 % Tween (PBS-T). After 
each addition the plates were washed with PBS-T.  HA was immobilized by 
applying in each well 60 ~tl of a solution containing 50 mg/ml of HA. For 
each determination of the binding of LP to HA, 180 ng of LP was first al- 
lowed to react with antibodies against peptide Gly~~  m and then added 
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Figure 1. Effect of soluble GAGs on the binding of LP to immobi- 
lized HA.  HA,  hyaluronic acid;  C-4,  chondroitin-4-sulfate; C-6, 
chondroitin-6-sulfate; DS, dermatan sulfate; HS, heparan sulfate; 
He, heparin; KS, keratan sulfate. The open circles represent the av- 
erage of the individual values for each of the six GAGs used at each 
concentration indicated. 
as a complex to an HA-coated well. Detection of bound LP was with a goat 
anti-rabbit IgG alkaline phosphatase conjugate  (1:400). The substrate was 
p-nitrophenyl phosphate (0.1%) in diethanolamine  (1 M), pH 9.8, containing 
L0 mM MgClz. LP was immobilized by applying in each well  10 gl of a 
solution containing  9 mg/ml of LE Binding of mAb 8A4 was monitored with 
goat anti-mouse IgG alkaline phosphatase conjugate 0:400) followed by the 
addition of substrate as indicated above. The optical density developed  in 
the ELISA was determined at 405 am in the linear portion of the colorimet- 
tic assay using a plate reader (Artek Systems Corp., Farmingdale,  NY). 
Glycosaminoglycans  (GAGs) were obtained through the courtesy  of Drs. 
M. B. Mathews and J. A. Cifonelli of The University of Chicago (Chicago, 
IL), Protein concentrations were determined with the BioRad Laboratories 
reagent  using BSA as a standard. 
Results 
Specificity of  the Binding  Assay 
Peptide Gly~~  was selected for the generation of anti- 
bodies to measure the interactions between LP and HA be- 
cause this peptide is situated in domain I of LP and this do- 
main was hypothesized not to be involved in the interaction 
with HA. Thus, the detecting antibody would not interfere 
with the measurement of the LP-HA interactions. 
The  specificity  of the  solid-phase  assay  for measuring 
LP-HA interactions was determined in competition experi- 
ments involving soluble GAGs.  The binding of LP to im- 
mobilized HA could be inhibited only with soluble HA and 
not  with  soluble  chondroitin-4-sulfate,  chondroitin-6-sul- 
fate,  dermatan sulfate, keratan  sulfate, heparin, or heparan 
sulfate (Fig.  1).  Furthermore,  when these GAGs were im- 
mobilized onto microtiter  plates,  binding of LP could be 
demonstrated only to HA (data not shown). 
The effect of ionic strength on both the maintenance and 
the establishment of the LP-HA interactions was investigated 
to determine if the observed interactions are ionic in nature. 
To test the maintenance of the interactions, LP was allowed 
to bind to immobilized HA in PBS-T and was subsequently 
washed with solutions of increasing concentration of NaC1. 
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Figure 2. Effect of NaC1 concentration  on the establishment and 
maintenance of LP binding to immobilized HA. (o  o) LP was 
added to the wells of microtiter plates in solutions of increasing lev- 
els of NaCI concentration.  (zx  zx) LP was added to the wells in 
0.15 M NaC1 and then washed with solutions of increasing NaCI 
concentrations. (e- -  -e) LP was immobilized to microtiter plates, 
challenged with antipeptide Gly~~  ltz antibodies and then washed 
with solutions of increasing NaCl concentrations. 
The binding of LP to HA decreased linearly as the NaCI con- 
centrations  were increased.  Similar  results  were obtained 
when the establishment of binding was tested at increasing 
concentrations of NaC1 (Fig. 2). These results indicate that 
ionic interactions play a large role in the binding of LP to HA 
in the assays used. To ascertain that the salt effect observed 
was not occurring at the level of binding of the anti-peptide 
antibody to LP, antibody was allowed to bind to immobilized 
LP and then washed with solutions of increasing salt concen- 
trations. Only a minor reduction in binding is observed at the 
higher salt concentrations used (Fig. 2). 
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Figure 3. Inhibition of binding of LP to immobilized HA with mAb 
8A4. Decreasing  quantities  of LP-antipeptide  antibody  complex 
were mixed with the same amount of the mAb 8A4 before the addi- 
tion to HA-coated microtiter plates.  C, control;  8,44, mAb 8A4. 
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Figure 4.  Schematic  representation of the tandcmJy  repeated  se- 
quences of chicken LP representing domains IIa and Ilb. The loca- 
tion of the synthetic peptides used in the study are indicated.  The 
dotted line representing the NH2-te~nal half of LP corresponds 
to domain I. 
Monoclonal Antibody (mAb) 8A4 Inhibits 
the Binding of  LP to HA 
mAb 8A4 is directed against epitopes on LP from a  large 
number of species (3). In the present study it was found that 
mAb 8A4 could inhibit the binding of LP to immobilized HA 
(Fig. 3). Solutions containing 180, 90, and 45 ng of LP were 
mixed with an equal quantity of mAb 8A4 culture superna- 
rant and added to HA-coated wells of microtiter plates. The 
amount of LP bound in control groups decreased in propor- 
tion to the amount of LP added. The inhibitory effect of mAb 
8A4 for each of the LP concentrations was 63, 74, and 87 %, 
respectively. Lowering the quantity of LP even further did 
not increase the inhibitory effect of the mAb 8A4 used. 
Identification of the Epitopes for mAb 8A4 
The epitopes recognized by mAb 8A4 have been localized on 
tryptic peptides that map between the two central cysteine 
residues located in domains IIa and IIb of LP (17). In an effort 
to map precisely the epitopes for mAb 8A4 a series of syn- 
thetic peptides were used in inhibition assays involving LP 
and mAb 8A4. The peptides used are designated on the dia- 
gram of the tandemly repeated sequences of LP in Fig.  4. 
The symbols, used in Fig.  4  to designate the peptides, are 
also used in later figures. The results of the addition of the 
various peptides on the binding of mAb 8A4 to LP are shown 
in  Fig.  5.  The two 20-amino  acid  peptides  (AsnE~ 
and  Asp~-Arg  325) situated  between  the  two  centrally  lo- 
cated cysteine residues of domains IIa and IIb, respectively, 
reduce the binding of mAb KA4 to LP at a concentration of 
10-6-10 -5  M.  The  two  10-amino  acid  sequences  (Gly  217- 
Pro  226 and Arg316-Arg  325) inhibit the binding of mAb 8A4 to 
LP to the same extent. These two peptides contain the posi- 
tively charged amino acid sequences between the two cen- 
trally located cysteine residues of domains IIa and IIb. In 
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Figure 5. Effect of synthetic LP pcptides on the binding ofmAb 8A4 
to immobilized LP. The symbols used arc those given in Fig. 4. 
contrast, two other sequences within domains IIa and lib that 
contain clusters of positively charged amino acids (Trp  2+2- 
Val  2m and Pro339-Va134s) fail to inhibit the binding of mAb 
8A4 to LP in that concentration range. Inhibition by these 
peptides could be demonstrated only at concentrations of 
10  -2 M  (data not shown). 
Peptide Inhibition of  LP  Binding to HA 
The ability of each of the peptides to inhibit the binding of 
LP to HA was investigated next. Fig. 6 A shows the effects 
of the three peptides from domain IIa. All three peptides in- 
hibit  the  interaction of LP with  HA in  a  similar dosage- 
dependent manner. The three peptides from domain IIb in- 
hibit the interaction between LP and HA to the same degree 
(Fig. 6 B). To test the possibility of cooperativity between 
the peptides, equimolar mixtures of the two 10--amino acid 
peptides  from  domain  IIa  (Fig.  5  C)  and  of  the  four 
10-amino acid peptides from domains IIa and lib (Fig. 6 D) 
were tested. Both mixtures inhibited the LP-HA interaction 
at a total molar concentration that was identical to the effec- 
tive concentrations of any one of the  individual peptides. 
That the inhibitions observed are a specific result of the LP 
peptides rather than from a nonspecific effect of the interac- 
tion of positively charged peptides with HA is evident from 
the inability of lysine peptides to show inhibition (Fig. 6 D). 
Discussion 
The data presented in this paper provide experimental evi- 
dence that supports the hypothesis that the HA-binding sites 
of LP are located in the tandemly repeated domains of this 
matrix molecule. The method for testing the interaction be- 
tween LP and HA was a solid-phase ELISA in which the de- 
tecting antibody was directed against a peptide sequence in 
a domain of LP predicted not to be in the HA-binding do- 
mains. The test, as developed, was specific for the interac- 
tions between LP and HA. The binding of LP to immobilized 
HA could be inhibited only by soluble HA and not by any 
other soluble GAGs tried. Furthermore, when GAGs were 
immobilized, LP binding could be demonstrated only to im- 
mobilized  HA.  The  LP-HA  interactions  measured  were 
largely of an ionic nature and they could be reduced with so- 
lutions of increasing ionic strength. At an NaCI concentra- 
tion of 1.0 M the binding of LP to HA was reduced by 40%. 
This value is very close to the 37 % inhibition observed by 
Tengblad (20) for the same NaCI concentration. 
The HA-binding sites of LP were identified in two ways. 
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Figure 6. Effect of  synthetic LP peptides 
on the binding of LP to immobilized 
HA.  (A)  Peptides  from  domain  IIa 
tested individually. (B) Peptides from 
domain  lib  tested  individually.  (C) 
Equimolar mixture of two peptides from 
domain IIA. (D) Equimolar mixture of 
four peptides, two from domain IIa and 
two from domain IIb. D  also demon- 
strates the lack of effect of lysine peptide 
on the LP-HA interaction. The symbols 
used are the same as those shown in the 
legend of Fig. 4. 
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hibited by mAb 8A4 and second that the two 10-amino acid 
peptides Gln2~7-Pro  2~ and Arg3~6-Arg325 could block the bind- 
ing of mAb 8A4 to LP. The identification of these two pep- 
tides as epitopes for mAb 8A4 extend the results of Neame 
et al. (16) who had shown that the antibody bound to LP in 
the 20-amino acid regions that are situated between the two 
centrally located cysteine residues of each of  the two repeats. 
The combination of the results of the mAb 8A4 blocking ex- 
periments and the identification of the epitopes for that anti- 
body permitted the identification of peptides Gln217-Pro  226 
and Arg3~6-Arg  325 as two sites on LP that are involved in the 
binding to HA. The fact that these two peptides are situated 
in the regions that show the highest degree of homology be- 
tween domains IIa and llb is consistent with the view that 
conserved sequences reflect a conservation of function. The 
results of the experiments in which the LP-HA interaction 
was blocked with mAb 8A4 were supported and extended 
with the results of  tests in which peptides were used to inhibit 
the binding between LP and HA. All the peptides that con- 
tain the epitopes for mAb 8A4 could compete with LP for 
binding to HA and thus inhibit the interaction between LP 
and HA.  In  addition,  peptide Trp~2-Val25t of domain IIa 
and peptide Pro339-Va134s of domain IIb could also inhibit 
the interaction of LP with HA. These two peptides also con- 
tain clusters of positively charged residues. Therefore, do- 
mains IIa and IIb each contain two peptides with clusters of 
positively charged amino acids that can inhibit the inter- 
action of LP with HA. Thus, the binding of LP to HA may 
involve  four or  more  subsites  of the  tandemly repeated 
domains. 
All the available evidence indicates that the interactions 
between LP and HA are largely of an ionic nature (12, 14, 
20, the present studies). The inhibitory effect of the LP pep- 
tides, therefore, could be the result of nonspecific blocking 
of binding sites on HA by the positively charged peptides. 
That this is not the case is evident from the results obtained 
with the polylysine peptide of 8-12 residues. This peptide 
was not able to inhibit the binding of LP to HA. Therefore, 
we conclude that the inhibitory effect of the LP peptides is 
specific. When peptides that could inhibit the LP-HA inter- 
action singly were mixed in equimolar combinations, there 
was no evidence of any cooperativity in the inhibition. These 
results are interpreted to mean that each peptide is probably 
recognizing the same site on HA and that it is the quantity 
of any one of the four peptides that recognize HA that is im- 
portant. Together the results indicate that LP can bind to HA 
through four different sites.  It is not possible to conclude 
from the present studies if there are primary and secondary 
sites of interaction. The observation that mAb 8A4 can in- 
hibit the binding of LP to HA by 87 % can be interpreted to 
mean that the two sites recognized by the antibody are pri- 
mary sites of interaction. Alternatively, the mAb blocking 
experiments can also be interpreted to mean that all four sites 
are needed for the binding of LP to HA. Indeed, in view of 
the highly repetitive structure of HA, multiple-binding sites 
may be necessary to provide sufficient  affinity  for LP to inter- 
act detectably with the GAG. The four sites on LP may be 
spaced for optimum binding to HA through the two disulfide 
bonds in each of the two repeated domains. This mechanism 
would explain why we have not been able to detect binding 
of the peptides directly to HA. 
Each of the tandemly repeated domains, Ha and IIb, con- 
tain four cysteine residues that form disulfide  bonds as shown 
in Fig. 4. A comparison of the amino acid sequence between 
the  most  NH:-  and  COOH-terminally  located  cysteine 
residues of each domain reveals that the homology between 
similar domains of different species is greater than the ho- 
mology between the two domains within a species. For ex- 
ample, the chicken-rat homologies are 90 and 94 % for do- 
mains IIa and IIb, respectively. In contrast, the homology 
between the sequences of  domains IIa and IIb of  both chicken 
and rat are 46 %. From an evolutionary point these calcula- 
tions would suggest that the duplications of the two domains 
occurred before the separation of birds and mammals. The 
homology between domains IIa and IIb within a species is 
highest for the sequences of 22 amino acids involving the two 
centrally located cysteine residues of each repeat. The ho- 
mology value for these regions is 68% for the chicken LP 
and 63 % for the rat LP. This relatively high degree of  homol- 
ogy between these two regions could be interpreted to mean 
that they contain conserved  functional domains.  Indeed, 
these sequences contain the epitope for mAb 8A4 and, there- 
fore, the conclusion based on homology between domains is 
in agreement with the experimental evidence presented in 
this study. However, the homology analysis does not address 
the question of  possible primary and secondary sites of inter- 
action with HA.  Experiments in which specific sites are 
modified by site-directed mutagenesis will help clarify this 
point. 
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